BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND LDH AND Prognosis
712 results:

  • 1. [Clinical Features and Prognostic Analysis of Newly Diagnosed Diffuse Large B-cell lymphoma Combined with Hemophagocytic Syndrome].
    Wei XF; Feng YF; Fu Y; Liu F; Chen QL; Zhang QK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):466-469. PubMed ID: 38660853
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Correlation Analysis of Peripheral Blood B Cell Count with Clinical Features and prognosis in Patients Newly Diagnosed with Diffuse Large B-Cell lymphoma].
    Lu T; Mi H; Zhao DD; Yang SG; Bu YW; Zhang F; Chen WM; Sun DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):458-465. PubMed ID: 38660852
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Expression of CD30 in Patients with Diffuse Large B-Cell lymphoma and Clinical Significance].
    Qu Y; Lu XZ; Wang RX; Hei XF; Li J; Xiao BT; Jia ZX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):450-457. PubMed ID: 38660851
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [The Value of Baseline PET/CT Imaging of Bone Marrow
    Wang Y; Zhao M; Yuan L; Li J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):439-444. PubMed ID: 38660849
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Development and validation of a novel prognostic nomogram for advanced diffuse large B cell lymphoma.
    Wan M; Zhang W; Huang H; Fang X; Chen Y; Tian Y; Yao Y; Weng H; Chen Z; Yu L; Tian Y; Huang H; Li X; Hong H; Lin T
    Clin Exp Med; 2024 Mar; 24(1):64. PubMed ID: 38554186
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Primary thyroid lymphoma: a case series.
    Sakhri S; Zemni I; Ayadi MA; Kamoun S; Chargui R; Ben Dhiab T
    J Med Case Rep; 2024 Feb; 18(1):108. PubMed ID: 38395921
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Characteristics and prognosis in Adult Patients with Early T-Cell Precursor Acute Lymphoblastic Leukemia/lymphoma from Multicenter].
    Li ZH; Luo L; Yang P; Li Y; Zou DH; Gao CJ; Jing HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):120-124. PubMed ID: 38387909
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Expression of MCP-1 and CCR2 in Newly Diagnosed Diffuse Large B-Cell lymphoma and Clinical Significance].
    Wang M; Zhang PP; Zhu Q; Hu ZL; Bai X; Wu YP; Li JJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):112-119. PubMed ID: 38387908
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Skeletal muscle index impacts the treatment outcome of elderly patients with diffuse large B cell lymphoma.
    Niiyama-Uchibori Y; Okamoto H; Miyashita A; Mizuhara K; Kanayama-Kawaji Y; Fujino T; Tsukamoto T; Mizutani S; Shimura Y; Teramukai S; Kuroda J
    Hematol Oncol; 2024 Jan; 42(1):e3252. PubMed ID: 38287527
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Low serum apolipoprotein A1 level predicts poor prognosis of patients with diffuse large B-cell lymphoma in the real world: a retrospective study.
    Huang X; Wang Y; Huang Z; Chen X; Lin Q; Huang H; Fan L
    BMC Cancer; 2024 Jan; 24(1):62. PubMed ID: 38212711
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Biological signatures of the International Prognostic Index in diffuse large B-cell lymphoma.
    Wang Y; Shi Q; Shi ZY; Tian S; Zhang MC; Shen R; Fu D; Dong L; Yi HM; Ouyang BS; Mu RJ; Cheng S; Wang L; Xu PP; Zhao WL
    Blood Adv; 2024 Apr; 8(7):1587-1599. PubMed ID: 38170757
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic value of lactate dehydrogenase, serum albumin and the lactate dehydrogenase/albumin ratio in patients with diffuse large B-cell lymphoma.
    Wu W; Miao L; Zhao L; Zhu Y; Mao J; Cai Z; Ji Y; Wang L; Wang Y; Jia T
    Hematology; 2024 Dec; 29(1):2293514. PubMed ID: 38108323
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Levels and Clinical Significances of sPD-1 and sPD-L1 in Peripheral Blood of lymphoma Patients].
    Liu XL; He P; Lei J; Zou LX; Peng L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1733-1738. PubMed ID: 38071053
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [The Clinical-Biological Features and prognosis of Patients with Mantle Cell lymphoma].
    Chen WZ; Liu TB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1726-1732. PubMed ID: 38071052
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Expression and Clinical Significance of Exosome Component 4 in Newly Diagnosed Patients with Diffuse Large B-Cell lymphoma].
    Hong JQ; Huang QH; Huang ZY; Fan LP; Lin QY; Huang HB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1684-1689. PubMed ID: 38071046
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Hemophagocytic lymphohistiocytosis: A retrospective analysis of 66 patients].
    Thiebaut L; Pasquier G; Theret S; Russello J
    Rev Med Interne; 2024 Jan; 45(1):6-12. PubMed ID: 37932192
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Richter transformation - retrospective treatment outcomes analysis in Polish Adult Leukemia Study Group.
    Sośnia O; Pruszczyk K; Danecki M; Wąsik-Szczepanek E; Tryc-Szponder J; Iskierka-Jażdżewska E; Majeranowski A; Krzemień H; Bołkun Ł; Paszkiewicz-Kozik E; Drozd-Sokołowska J; Kwiatkowski J; Wiśniewska-Organek D; Prochorec-Sobieszek M; Szumera-Ciećkiewicz A; Budziszewska B; Jamroziak K; Hus I; Lech-Marańda E; Puła B
    Leuk Lymphoma; 2024 Feb; 65(2):175-186. PubMed ID: 37921067
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Predictive value of Dmax and %ΔSUVmax of
    Dang J; Peng X; Wu P; Yao Y; Tan X; Ye Z; Jiang X; Jiang X; Liu Y; Chen S; Cheng Z
    BMC Med Imaging; 2023 Oct; 23(1):173. PubMed ID: 37907837
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Comparative analysis of clinicopathologic characteristics and prognosis between nasal and nonnasal extranodal NK/T-cell lymphoma.
    Shen Z; Chen X; Sun C; Lu T; Shi Y; Zhang H; Ye J; Wang L; Zhu T; Miao Y; Zhang X; Wang L; Cai G; Sang W
    Cancer Med; 2023 Dec; 12(23):21138-21147. PubMed ID: 37902266
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Development and validation of a novel risk stratification model and a survival rate calculator for diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study.
    Zhong Q; Chen H; Chen D; Qin Y; He X; Yang Y; Yang J; Liu P; Zhou S; Yang S; Zhou Y; Tang L; Chen C; Shi Y
    Ann Hematol; 2024 Jan; 103(1):211-226. PubMed ID: 37861735
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 36.